midodrine has been researched along with Disease Exacerbation in 2 studies
Midodrine: An ethanolamine derivative that is an adrenergic alpha-1 agonist. It is used as a vasoconstrictor agent in the treatment of HYPOTENSION.
midodrine : An aromatic ether that is 1,4-dimethoxybenzene which is substituted at position 2 by a 2-(glycylamino)-1-hydroxyethyl group. A direct-acting sympathomimetic with selective alpha-adrenergic agonist activity, it is used (generally as its hydrochloride salt) as a peripheral vasoconstrictor in the treatment of certain hypotensive states. The main active moiety is its major metabolite, deglymidodrine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maddukuri, G | 1 |
| Cai, CX | 1 |
| Munigala, S | 1 |
| Mohammadi, F | 1 |
| Zhang, Z | 1 |
| Skagen, C | 1 |
| Einstein, M | 1 |
| Lucey, MR | 1 |
| Said, A | 1 |
2 other studies available for midodrine and Disease Exacerbation
| Article | Year |
|---|---|
Targeting an early and substantial increase in mean arterial pressure is critical in the management of type 1 hepatorenal syndrome: a combined retrospective and pilot study.
Topics: Albumins; Arterial Pressure; Disease Progression; Disease-Free Survival; Drug Therapy, Combination; | 2014 |
Combination treatment with octreotide, midodrine, and albumin improves survival in patients with type 1 and type 2 hepatorenal syndrome.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Albumins; Cohort Studies; Disease Progression; Drug Therapy, | 2009 |